K. Beerblock

742 total citations
22 papers, 532 citations indexed

About

K. Beerblock is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, K. Beerblock has authored 22 papers receiving a total of 532 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 4 papers in Surgery and 4 papers in Molecular Biology. Recurrent topics in K. Beerblock's work include Colorectal Cancer Treatments and Studies (7 papers), Cancer Treatment and Pharmacology (7 papers) and Drug Transport and Resistance Mechanisms (3 papers). K. Beerblock is often cited by papers focused on Colorectal Cancer Treatments and Studies (7 papers), Cancer Treatment and Pharmacology (7 papers) and Drug Transport and Resistance Mechanisms (3 papers). K. Beerblock collaborates with scholars based in France and United States. K. Beerblock's co-authors include Christophe Louvet, Aimery de Gramont, Élisabeth Carola, Thierry André, Éric François, Virginie Lucas, Françoise Desseigne, Yacine Merrouche, F. Morvan and Olivier Bouché and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.

In The Last Decade

K. Beerblock

22 papers receiving 517 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K. Beerblock France 10 404 134 95 85 75 22 532
Maria Vadiaka Greece 13 423 1.0× 194 1.4× 67 0.7× 19 0.2× 75 1.0× 37 697
Hande Turna Türkiye 12 179 0.4× 159 1.2× 74 0.8× 45 0.5× 79 1.1× 51 448
Nicoletta Ravarino Italy 11 244 0.6× 82 0.6× 68 0.7× 164 1.9× 142 1.9× 25 517
Serenella Civitelli Italy 12 372 0.9× 209 1.6× 141 1.5× 19 0.2× 143 1.9× 29 594
C. Haberl Germany 11 173 0.4× 158 1.2× 41 0.4× 37 0.4× 83 1.1× 19 419
Susie Chin South Korea 10 198 0.5× 224 1.7× 58 0.6× 57 0.7× 97 1.3× 33 564
G. Tanzini Italy 12 388 1.0× 165 1.2× 120 1.3× 15 0.2× 138 1.8× 27 554
S Nasca France 8 407 1.0× 165 1.2× 44 0.5× 63 0.7× 171 2.3× 17 588
Jen Kou Lin Taiwan 10 219 0.5× 117 0.9× 68 0.7× 15 0.2× 195 2.6× 16 436
E Piana Italy 11 390 1.0× 340 2.5× 47 0.5× 18 0.2× 109 1.5× 28 592

Countries citing papers authored by K. Beerblock

Since Specialization
Citations

This map shows the geographic impact of K. Beerblock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Beerblock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Beerblock more than expected).

Fields of papers citing papers by K. Beerblock

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Beerblock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Beerblock. The network helps show where K. Beerblock may publish in the future.

Co-authorship network of co-authors of K. Beerblock

This figure shows the co-authorship network connecting the top 25 collaborators of K. Beerblock. A scholar is included among the top collaborators of K. Beerblock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Beerblock. K. Beerblock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Laroche, F., Serge Perrot, Paul Cottu, et al.. (2017). Quality of life and impact of pain in women treated with aromatase inhibitors for breast cancer. A multicenter cohort study. PLoS ONE. 12(11). e0187165–e0187165. 35 indexed citations
2.
3.
Lévy, Pierre, Joseph Gligorov, Martine Antoine, et al.. (2013). Influence of ABCB1 polymorphisms and docetaxel pharmacokinetics on pathological response to neoadjuvant chemotherapy in breast cancer patients. Breast Cancer Research and Treatment. 139(2). 421–428. 17 indexed citations
4.
Fajac, Anne, Joseph Gligorov, Keyvan Rezaï, et al.. (2010). Effect of ABCB1 C3435T polymorphism on docetaxel pharmacokinetics according to menopausal status in breast cancer patients. British Journal of Cancer. 103(4). 560–566. 28 indexed citations
5.
Gligorov, Joseph, Frédèric Selle, Éric Levy, et al.. (2007). ABCB1 (MDR1) genotype in relation to doxorubicin and docetaxel pharmacokinetics in patients with breast cancer. Cancer Research. 67. 729–729. 1 indexed citations
6.
Avenin, D., Joseph Gligorov, Frédèric Selle, et al.. (2005). Analogues de la LHRH : leur utilisation dans le traitement du cancer du sein en situation métastatique et adjuvante☆. Gynécologie Obstétrique & Fertilité. 33(11). 914–919. 2 indexed citations
7.
Louvet, Christophe, Fabrice Carrat, Frédéric Mal, et al.. (2003). Prognostic Factor Analysis in Advanced Gastric Cancer Patients Treated with Hydroxyurea, Leucovorin, 5-Fluorouracil, and Cisplatin (HLFP Regimen). Cancer Investigation. 21(1). 14–20. 19 indexed citations
8.
André, Thierry, M.A. Bensmaïne, Christophe Louvet, et al.. (1999). Multicenter Phase II Study of Bimonthly High-Dose Leucovorin, Fluorouracil Infusion, and Oxaliplatin for Metastatic Colorectal Cancer Resistant to the Same Leucovorin and Fluorouracil Regimen. Journal of Clinical Oncology. 17(11). 3560–3568. 238 indexed citations
9.
Beerblock, K., Yves Rinaldi, Christophe Louvet, et al.. (1997). Bimonthly high dose leucovorin and 5-fluorouracil 48-hour continuous infusion in patients with advanced colorectal carcinoma. Cancer. 79(6). 1100–1105. 27 indexed citations
10.
11.
Louvet, C., et al.. (1996). Dual modulation of 5-fluorouracil with folinic acid and hydroxyurea in metastatic colorectal cancer.. PubMed. 6(2). 97–101. 12 indexed citations
12.
Louvet, C., Aimery de Gramont, K. Beerblock, et al.. (1995). 557 Hydroxyurea, folinic acid, 5FU bolus and infusion (HLFP regimen) in advanced gastric cancer. European Journal of Cancer. 31. S119–S119. 1 indexed citations
13.
Louvet, Christophe, et al.. (1994). Découverte d'un adénocarcinome ovarien à l'occasion d'un accident vasculaire cérébral associé à une coagulopathie de consommation. La Revue de Médecine Interne. 15(1). 48–51. 1 indexed citations
14.
Louvet, C., Aimery de Gramont, K. Beerblock, et al.. (1993). Folinic acid, 5-fluorouracil bolus and infusion and mitoxantrone with or without cyclophosphamide in metastatic breast cancer. European Journal of Cancer. 29(13). 1835–1838. 2 indexed citations
15.
Gramont, Aimery de, et al.. (1993). Toxicité du lévamisole dans la chimiothérapie adjuvante du cancer colorectal. La Revue de Médecine Interne. 14(9). 821–824. 1 indexed citations
16.
17.
Milleron, B., et al.. (1992). [Should the extended evaluation of bronchial adenocarcinoma be different from that of non-small cell lung carcinoma?].. PubMed. 48(4). 159–62. 2 indexed citations
18.
Dréno, Brigitte, A Claudy, J Meynadier, et al.. (1991). The treatment of 45 patients with cutaneous T-cell lymphoma with low doses of interferon-α2a and etretinate. British Journal of Dermatology. 125(5). 456–459. 53 indexed citations
19.
Avril, Marie‐Françoise, K. Beerblock, Brigitte Dréno, et al.. (1990). [Treatment of metastatic melanoma with dacarbazine recombinant interferon alfa 2A combination: results of multicentric study].. PubMed. 77(12). 1183–91. 1 indexed citations
20.
Lokiec, François, et al.. (1989). [Study of the clinical pharmacokinetics of fotemustine in various tumor indications].. PubMed. 76(10). 1063–9. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria Vadiaka Breakdown of academic impact, for papers by Hande Turna Breakdown of academic impact, for papers by Nicoletta Ravarino Breakdown of academic impact, for papers by Serenella Civitelli Breakdown of academic impact, for papers by C. Haberl Breakdown of academic impact, for papers by Susie Chin Breakdown of academic impact, for papers by G. Tanzini Breakdown of academic impact, for papers by S Nasca Breakdown of academic impact, for papers by Jen Kou Lin Breakdown of academic impact, for papers by E Piana
Rankless by CCL
2026